NGF and astrocytoma (excluding glioblastoma): They discovered that complanadine A exhibited neurotrophic activity by enhancing the mRNA expression level for nerve growth factor (NGF) biosynthesis in 1321N1 human astrocytoma cells and NGF production in human glial cells, rendering complanadine A a promising lead compound for neurological disorder treatment.